{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:14:11Z","timestamp":1782450851008,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/onc.2017.318","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T15:05:11Z","timestamp":1505142311000},"page":"174-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking"],"prefix":"10.1038","volume":"37","author":[{"given":"D P","family":"Corkery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L E","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gebremeskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Salsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Le Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-M","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J N","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3466-6316","authenticated-orcid":false,"given":"G","family":"Dellaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"BFonc2017318_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H . Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619\u2013626.","journal-title":"J Cell Biol"},{"key":"BFonc2017318_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0955-0674(97)80124-X","volume":"9","author":"SM Frisch","year":"1997","unstructured":"Frisch SM, Ruoslahti E . Integrins and anoikis. Curr Opin Cell Biol 1997; 9: 701\u2013706.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2017318_CR3","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1038\/71397","volume":"2","author":"FG Giancotti","year":"2000","unstructured":"Giancotti FG . Complexity and specificity of integrin signalling. Nat Cell Biol 2000; 2: E13\u2013E14.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017318_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1023\/A:1023725029589","volume":"22","author":"V Gabarra-Niecko","year":"2003","unstructured":"Gabarra-Niecko V, Schaller MD, Dunty JM . FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 2003; 22: 359\u2013374.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc2017318_CR5","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1093\/emboj\/17.22.6622","volume":"17","author":"L Moro","year":"1998","unstructured":"Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L et al. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 1998; 17: 6622\u20136632.","journal-title":"EMBO J"},{"key":"BFonc2017318_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ncb1026","volume":"5","author":"MJ Reginato","year":"2003","unstructured":"Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 2003; 5: 733\u2013740.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017318_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1074\/jbc.M110.169821","volume":"286","author":"AR Grassian","year":"2011","unstructured":"Grassian AR, Schafer ZT, Brugge JS . ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. J Biol Chem 2011; 286: 79\u201390.","journal-title":"J Biol Chem"},{"key":"BFonc2017318_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF00273617","volume":"226","author":"GH Rosenberg","year":"1991","unstructured":"Rosenberg GH, Alahari SK, Kaufer NF . prp4 from Schizosaccharomyces pombe, a mutant deficient in pre-mRNA splicing isolated using genes containing artificial introns. Mol Gen Genet 1991; 226: 305\u2013309.","journal-title":"Mol Gen Genet"},{"key":"BFonc2017318_CR9","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1128\/MCB.22.14.5141-5156.2002","volume":"22","author":"G Dellaire","year":"2002","unstructured":"Dellaire G, Makarov EM, Cowger JM, Longman D, Sutherland HGE, Luhrmann R et al. Mammalian PRP4 kinase copurifies and interacts with components of both the U5 snRNP and the N-CoR deacetylase complexes. Mol Cell Biol 2002; 22: 5141\u20135156.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017318_CR10","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/15384101.2015.1007775","volume":"14","author":"DP Corkery","year":"2015","unstructured":"Corkery DP, Le Page C, Meunier L, Provencher D, Mes-Masson AM, Dellaire G . PRP4K is a HER2-regulated modifier of taxane sensitivity. Cell Cycle 2015; 14: 1059\u20131069.","journal-title":"Cell Cycle"},{"key":"BFonc2017318_CR11","doi-asserted-by":"publisher","first-page":"32247","DOI":"10.1074\/jbc.M103790200","volume":"276","author":"T Kojima","year":"2001","unstructured":"Kojima T, Zama T, Wada K, Onogi H, Hagiwara M . Cloning of human PRP4 reveals interaction with Clk1. J Biol Chem 2001; 276: 32247\u201332256.","journal-title":"J Biol Chem"},{"key":"BFonc2017318_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1083\/jcb.200703133","volume":"179","author":"E Montembault","year":"2007","unstructured":"Montembault E, Dutertre S, Prigent C, Giet R . PRP4 is a spindle assembly checkpoint protein required for MPS1, MAD1, and MAD2 localization to the kinetochores. J Cell Biol 2007; 179: 601\u2013609.","journal-title":"J Cell Biol"},{"key":"BFonc2017318_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nsmb.1718","volume":"17","author":"M Schneider","year":"2010","unstructured":"Schneider M, Hsiao HH, Will CL, Giet R, Urlaub H, Luhrmann R . Human PRP4 kinase is required for stable tri-snRNP association during spliceosomal B complex formation. Nat Struct Mol Biol 2010; 17: 216\u2013221.","journal-title":"Nat Struct Mol Biol"},{"key":"BFonc2017318_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nmeth.2171","volume":"9","author":"AJ Lam","year":"2012","unstructured":"Lam AJ, St-Pierre F, Gong Y, Marshall JD, Cranfill PJ, Baird MA et al. Improving FRET dynamic range with bright green and red fluorescent proteins. Nat Methods 2012; 9: 1005\u20131012.","journal-title":"Nat Methods"},{"key":"BFonc2017318_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/35052055","volume":"2","author":"M Zerial","year":"2001","unstructured":"Zerial M, McBride H . Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2001; 2: 107\u2013117.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2017318_CR16","doi-asserted-by":"publisher","first-page":"24131","DOI":"10.1074\/jbc.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H et al. p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007; 282: 24131\u201324145.","journal-title":"J Biol Chem"},{"key":"BFonc2017318_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/17618","volume":"397","author":"S Christoforidis","year":"1999","unstructured":"Christoforidis S, McBride HM, Burgoyne RD, Zerial M . The Rab5 effector EEA1 is a core component of endosome docking. Nature 1999; 397: 621\u2013625.","journal-title":"Nature"},{"key":"BFonc2017318_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","volume":"13","author":"EL Eskelinen","year":"2003","unstructured":"Eskelinen EL, Tanaka Y, Saftig P . At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 2003; 13: 137\u2013145.","journal-title":"Trends Cell Biol"},{"key":"BFonc2017318_CR19","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1016\/S0021-9258(18)99131-3","volume":"266","author":"HS Wiley","year":"1991","unstructured":"Wiley HS, Herbst JJ, Walsh BJ, Lauffenburger DA, Rosenfeld MG, Gill GN . The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem 1991; 266: 11083\u201311094.","journal-title":"J Biol Chem"},{"key":"BFonc2017318_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","volume":"24","author":"A Tomas","year":"2014","unstructured":"Tomas A, Futter CE, Eden ER . EGF receptor trafficking: consequences for signaling and cancer. Trends Cell Biol 2014; 24: 26\u201334.","journal-title":"Trends Cell Biol"},{"key":"BFonc2017318_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1083\/jcb.201601090","volume":"215","author":"S Scharaw","year":"2016","unstructured":"Scharaw S, Iskar M, Ori A, Boncompain G, Laketa V, Poser I et al. The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR. J Cell Biol 2016; 215: 543\u2013558.","journal-title":"J Cell Biol"},{"key":"BFonc2017318_CR22","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1016\/S0021-9258(19)89171-8","volume":"261","author":"HS Earp","year":"1986","unstructured":"Earp HS, Austin KS, Blaisdell J, Rubin RA, Nelson KG, Lee LW et al. Epidermal growth factor (EGF) stimulates EGF receptor synthesis. J Biol Chem 1986; 261: 4777\u20134780.","journal-title":"J Biol Chem"},{"key":"BFonc2017318_CR23","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1091\/mbc.12.5.1519","volume":"12","author":"M Jost","year":"2001","unstructured":"Jost M, Huggett TM, Kari C, Rodeck U . Matrix-independent survival of human keratinocytes through an EGF receptor\/MAPK-kinase-dependent pathway. Mol Biol Cell 2001; 12: 1519\u20131527.","journal-title":"Mol Biol Cell"},{"key":"BFonc2017318_CR24","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/nature02765","volume":"430","author":"S Douma","year":"2004","unstructured":"Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS . Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004; 430: 1034\u20131039.","journal-title":"Nature"},{"key":"BFonc2017318_CR25","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1038\/onc.2011.96","volume":"30","author":"MA Smit","year":"2011","unstructured":"Smit MA, Peeper DS . Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene 2011; 30: 3735\u20133744.","journal-title":"Oncogene"},{"key":"BFonc2017318_CR26","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1128\/MCB.01164-08","volume":"29","author":"MA Smit","year":"2009","unstructured":"Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS . A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 2009; 29: 3722\u20133737.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017318_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1365-2141.2011.08661.x","volume":"153","author":"DP Corkery","year":"2011","unstructured":"Corkery DP, Dellaire G, Berman JN . Leukaemia xenotransplantation in zebrafish\u2013chemotherapy response assay in vivo. Br J Haematol 2011; 153: 786\u2013789.","journal-title":"Br J Haematol"},{"key":"BFonc2017318_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan DS, Agarwal R, Kaye SB . Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 2006; 7: 925\u2013934.","journal-title":"Lancet Oncol"},{"key":"BFonc2017318_CR29","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/onc.2014.264","volume":"34","author":"Q Cai","year":"2014","unstructured":"Cai Q, Yan L, Xu Y . Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene 2014; 34: 3315\u20133324.","journal-title":"Oncogene"},{"key":"BFonc2017318_CR30","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P . Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta 2013; 1833: 3481\u20133498.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2017318_CR31","doi-asserted-by":"publisher","first-page":"37273","DOI":"10.1074\/jbc.M106424200","volume":"276","author":"K Rosen","year":"2001","unstructured":"Rosen K, Coll ML, Li A, Filmus J . Transforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cells. J Biol Chem 2001; 276: 37273\u201337279.","journal-title":"J Biol Chem"},{"key":"BFonc2017318_CR32","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/cdd.2008.3","volume":"15","author":"E Giannoni","year":"2008","unstructured":"Giannoni E, Buricchi F, Grimaldi G, Parri M, Cialdai F, Taddei ML et al. Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ 2008; 15: 867\u2013878.","journal-title":"Cell Death Differ"},{"key":"BFonc2017318_CR33","doi-asserted-by":"publisher","first-page":"7279","DOI":"10.1128\/MCB.22.20.7279-7290.2002","volume":"22","author":"Y Wang","year":"2002","unstructured":"Wang Y, Pennock S, Chen X, Wang Z . Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol Cell Biol 2002; 22: 7279\u20137290.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017318_CR34","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/ncb3250","volume":"17","author":"J Alanko","year":"2015","unstructured":"Alanko J, Mai A, Jacquemet G, Schauer K, Kaukonen R, Saari M et al. Integrin endosomal signalling suppresses anoikis. Nat Cell Biol 2015; 17: 1412\u20131421.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017318_CR35","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1158\/1078-0432.CCR-06-0317","volume":"12","author":"LN Nguyen","year":"2006","unstructured":"Nguyen LN, Holdren MS, Nguyen AP, Furuya MH, Bianchini M, Levy E et al. Sorting nexin 1 down-regulation promotes colon tumorigenesis. Clin Cancer Res 2006; 12: 6952\u20136959.","journal-title":"Clin Cancer Res"},{"key":"BFonc2017318_CR36","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1128\/MCB.26.5.1754-1769.2006","volume":"26","author":"MJ Martin","year":"2006","unstructured":"Martin MJ, Melnyk N, Pollard M, Bowden M, Leong H, Podor TJ et al. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. Mol Cell Biol 2006; 26: 1754\u20131769.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017318_CR37","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/emboj\/16.10.2783","volume":"16","author":"A Khwaja","year":"1997","unstructured":"Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J . Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B\/Akt cellular survival pathway. EMBO J 1997; 16: 2783\u20132793.","journal-title":"EMBO J"},{"key":"BFonc2017318_CR38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.molcel.2014.03.007","volume":"54","author":"P Wang","year":"2014","unstructured":"Wang P, Zhou Z, Hu A, Ponte de Albuquerque C, Zhou Y, Hong L et al. Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt. Mol Cell 2014; 54: 378\u2013391.","journal-title":"Mol Cell"},{"key":"BFonc2017318_CR39","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1093\/nar\/25.5.1028","volume":"25","author":"T Gross","year":"1997","unstructured":"Gross T, Lutzelberger M, Weigmann H, Klingenhoff A, Shenoy S, Kaufer NF . Functional analysis of the fission yeast Prp4 protein kinase involved in pre-mRNA splicing and isolation of a putative mammalian homologue. Nucleic Acids Res 1997; 25: 1028\u20131035.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2017318_CR40","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/369678a0","volume":"369","author":"JF Gui","year":"1994","unstructured":"Gui JF, Lane WS, Fu XD . A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 1994; 369: 678\u2013682.","journal-title":"Nature"},{"key":"BFonc2017318_CR41","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1083\/jcb.145.6.1145","volume":"145","author":"N Kataoka","year":"1999","unstructured":"Kataoka N, Bachorik JL, Dreyfuss G . Transportin-SR, a nuclear import receptor for SR proteins. J Cell Biol 1999; 145: 1145\u20131152.","journal-title":"J Cell Biol"},{"key":"BFonc2017318_CR42","doi-asserted-by":"publisher","first-page":"10154","DOI":"10.1073\/pnas.181354098","volume":"98","author":"MC Lai","year":"2001","unstructured":"Lai MC, Lin RI, Tarn WY . Transportin-SR2 mediates nuclear import of phosphorylated SR proteins. Proc Natl Acad Sci USA 2001; 98: 10154\u201310159.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017318_CR43","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1074\/jbc.275.11.7950","volume":"275","author":"MC Lai","year":"2000","unstructured":"Lai MC, Lin RI, Huang SY, Tsai CW, Tarn WY . A human importin-beta family protein, transportin-SR2, interacts with the phosphorylated RS domain of SR proteins. J Biol Chem 2000; 275: 7950\u20137957.","journal-title":"J Biol Chem"},{"key":"BFonc2017318_CR44","doi-asserted-by":"publisher","first-page":"10824","DOI":"10.1073\/pnas.91.23.10824","volume":"91","author":"JF Gui","year":"1994","unstructured":"Gui JF, Tronchere H, Chandler SD, Fu XD . Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. Proc Natl Acad Sci USA 1994; 91: 10824\u201310828.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017318_CR45","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdl499","volume":"18","author":"AA Ayantunde","year":"2007","unstructured":"Ayantunde AA, Parsons SL . Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol 2007; 18: 945\u2013949.","journal-title":"Ann Oncol"},{"key":"BFonc2017318_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","volume":"3","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Stenvers KL . Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol 2013; 3: 256.","journal-title":"Front Oncol"},{"key":"BFonc2017318_CR47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/00000658-198606000-00009","volume":"203","author":"RN Garrison","year":"1986","unstructured":"Garrison RN, Kaelin LD, Galloway RH, Heuser LS . Malignant ascites. Clinical and experimental observations. Ann Surg 1986; 203: 644\u2013651.","journal-title":"Ann Surg"},{"key":"BFonc2017318_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0748-7983(96)80009-6","volume":"22","author":"SL Parsons","year":"1996","unstructured":"Parsons SL, Lang MW, Steele RJ . Malignant ascites: a 2-year review from a teaching hospital. Eur J Surg Oncol 1996; 22: 237\u2013239.","journal-title":"Eur J Surg Oncol"},{"key":"BFonc2017318_CR49","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jamcollsurg.2004.01.035","volume":"198","author":"RA Adam","year":"2004","unstructured":"Adam RA, Adam YG . Malignant ascites: past, present, and future. J Am Coll Surg 2004; 198: 999\u20131011.","journal-title":"J Am Coll Surg"},{"key":"BFonc2017318_CR50","first-page":"1663","volume":"32","author":"GB Feldman","year":"1972","unstructured":"Feldman GB, Knapp RC, Order SE, Hellman S . The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res 1972; 32: 1663\u20131666.","journal-title":"Cancer Res"},{"key":"BFonc2017318_CR51","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1200\/JCO.1996.14.6.1895","volume":"14","author":"MA Bookman","year":"1996","unstructured":"Bookman MA, McGuire WP 3rd, Kilpatrick D, Keenan E, Hogan WM, Johnson SW et al. Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group. J Clin Oncol 1996; 14: 1895\u20131902.","journal-title":"J Clin Oncol"},{"key":"BFonc2017318_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199601043340101","volume":"334","author":"WP McGuire","year":"1996","unstructured":"McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1\u20136.","journal-title":"N Engl J Med"},{"key":"BFonc2017318_CR53","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003; 21: 3194\u20133200.","journal-title":"J Clin Oncol"},{"key":"BFonc2017318_CR54","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1158\/1078-0432.CCR-04-0683","volume":"10","author":"TJ Herzog","year":"2004","unstructured":"Herzog TJ . Recurrent ovarian cancer: how important is it to treat to disease progression? Clin Cancer Res 2004; 10: 7439\u20137449.","journal-title":"Clin Cancer Res"},{"key":"BFonc2017318_CR55","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.1992.10.9.1485","volume":"10","author":"M Markman","year":"1992","unstructured":"Markman M, Rowinsky E, Hakes T, Reichman B, Jones W, Lewis JL Jr et al. Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study. J Clin Oncol 1992; 10: 1485\u20131491.","journal-title":"J Clin Oncol"},{"key":"BFonc2017318_CR56","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","unstructured":"Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609\u2013615.","journal-title":"Nature"},{"key":"BFonc2017318_CR57","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/1471-2407-12-379","volume":"12","author":"IJ Letourneau","year":"2012","unstructured":"Letourneau IJ, Quinn MC, Wang LL, Portelance L, Caceres KY, Cyr L et al. Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer. BMC Cancer 2012; 12: 379.","journal-title":"BMC Cancer"},{"key":"BFonc2017318_CR58","doi-asserted-by":"publisher","first-page":"e38541","DOI":"10.1371\/journal.pone.0038541","volume":"7","author":"C Le Page","year":"2012","unstructured":"Le Page C, Marineau A, Bonza PK, Rahimi K, Cyr L, Labouba I et al. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. PloS One 2012; 7: e38541.","journal-title":"PloS One"},{"key":"BFonc2017318_CR59","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","volume":"21","author":"KF Roby","year":"2000","unstructured":"Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, Tawfik O et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 2000; 21: 585\u2013591.","journal-title":"Carcinogenesis"},{"key":"BFonc2017318_CR60","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/humu.21029","volume":"30","author":"K Bedard","year":"2009","unstructured":"Bedard K, Attar H, Bonnefont J, Jaquet V, Borel C, Plastre O et al. Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation. Hum Mutat 2009; 30: 1123\u20131133.","journal-title":"Hum Mutat"},{"key":"BFonc2017318_CR61","doi-asserted-by":"publisher","first-page":"9379","DOI":"10.1093\/nar\/gkv993","volume":"43","author":"J Pinder","year":"2015","unstructured":"Pinder J, Salsman J, Dellaire G . Nuclear domain 'knock-in' screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing. Nucleic acids Res 2015; 43: 9379\u20139392.","journal-title":"Nucleic acids Res"},{"key":"BFonc2017318_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 2013; 339: 819\u2013823.","journal-title":"Science"},{"key":"BFonc2017318_CR63","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C . Clonogenic assay of cells in vitro. Nat Protoc 2006; 1: 2315\u20132319.","journal-title":"Nat Protoc"},{"key":"BFonc2017318_CR64","doi-asserted-by":"publisher","first-page":"e995562","DOI":"10.1080\/2162402X.2014.995562","volume":"4","author":"S Gebremeskel","year":"2015","unstructured":"Gebremeskel S, Clattenburg DR, Slauenwhite D, Lobert L, Johnston B . Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice. Oncoimmunology 2015; 4: e995562.","journal-title":"Oncoimmunology"},{"key":"BFonc2017318_CR65","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.","journal-title":"Sci Signal"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2017318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2017318","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/onc2017318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T05:01:51Z","timestamp":1684472511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2017318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFonc2017318"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.318","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]},"assertion":[{"value":"5 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}